Target intelligence / Profile preview

Pancreatic triacylglycerol lipase (PTL)

Target
PTL
Molecular classification
Enzyme (specifically, carboxylic ester hydrolase), Member of the pancreatic lipase family/class 3 lipases
01

Overview

Pancreatic triacylglycerol lipase is an enzyme secreted by the pancreas that plays a central role in dietary fat digestion. It catalyzes the hydrolysis of triglycerides at positions 1 and 3 on glycerol backbones within emulsified lipid droplets in the small intestine—producing mainly monoglycerides and free fatty acids that can be absorbed by enterocytes. This process requires colipase for optimal activity at lipid-water interfaces. The enzyme’s structure features a catalytic triad typical of serine hydrolases with an active site covered by a lid domain that undergoes conformational change upon substrate binding/interfacial activation. Clinically, it serves both as a drug target for anti-obesity agents like orlistat—which block its function—and as a biomarker for acute pancreatitis when found elevated in serum.

Other names
Pancreatic lipaseTriacylglycerol acyl hydrolaseTriglyceride lipaseSteapsinPLPTLEC 3.1.1.3
02

Mechanism of action

Inhibition of enzymatic activity to reduce hydrolysis/absorption of dietary fats; e.g., orlistat covalently binds to the active site serine residue, blocking substrate access and thus fat digestion/absorption

03

Biological functions

Hydrolysis of dietary triglycerides into monoglycerides and free fatty acids for absorption in the intestineFat metabolism/digestion
04

Disease associations

Obesity (targeted by anti-obesity drugs)Acute pancreatitis (diagnostic biomarker)Malabsorption syndromes (deficiency or inhibition can cause fat malabsorption)
05

Safety considerations

Inhibition may lead to gastrointestinal side effects such as steatorrhea (fatty stools), diarrhea, flatulence due to unabsorbed fats.Long-term inhibition could potentially affect absorption of fat-soluble vitamins.
06

Interacting drugs

Orlistat (approved inhibitor for obesity treatment)

1 more in the full profile.

07

Biomarkers

Serum pancreatic lipase levels are used as a diagnostic marker for acute pancreatitis and other pancreatic disorders

Beyond the preview

Go deeper on Pancreatic triacylglycerol lipase (PTL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pancreatic triacylglycerol lipase (PTL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call